With rigorous economic research and practical policy solutions, we focus on the issues and institutions that are critical to global development. Explore our core themes and topics to learn more about our work.
In timely and incisive analysis, our experts parse the latest development news and devise practical solutions to new and emerging challenges. Our events convene the top thinkers and doers in global development.
This event will be held at Sarova Stanley Hotel the during the Nairobi Summit on ICPD25.
Join the Center for Global Development and PAI for a discussion with country policymakers, health financing experts, and the broader family planning community to explore how advocates and governments can work together as constructive partners in the design of UHC-oriented financing policies to ensure universal and high-quality family planning access. The reception followed by an interactive panel discussion.
• Francis Asenso-Boadi, Director, Provider Payment, National Health Insurance Scheme, Ghana
• Felice Apter, Visiting Fellow, Center for Global Development
• Anne Coolen, Country Director, Marie Stopes Ghana
• Elisha Dunn-Georgiou, Vice President of Policy and Advocacy, PA
• Amos Mwale, Executive Director, Centre for Reproductive Health and Education
• Wesley Mwambazi, Assistant Director for Health Care Financing, Ministry of Health, Zambia
• Wangui Muthigani Mbuthia, UHC Secretariat, Service Delivery, Ministry of Health, Kenya
ABOUT THE EVENT
As countries aspire to achieve affordable healthcare for all, universal health coverage (UHC) is high on the global development agenda. But for UHC to become reality, decisionmakers must make difficult choices about how to use limited health resources. Defining a health benefits package policy can help governments prioritize the highest-value investments amidst competing priorities and interest groups. Within this broader landscape, countries have also committed to advance sexual and reproductive health and rights for women and girls. What are the opportunities and challenges to ensuring family planning is embedded within UHC policy and benefits package design? How does this process consider the direct impact on women’s and girls’ access to critical services? How can the family planning community effectively engage in the UHC agenda, including health financing reforms? Where are opportunities to work alongside government counterparts toward mutual goals?
Join the Center for Global Development and PAI for a discussion with country policymakers, health financing experts, and the broader family planning community to explore how advocates and governments can work together as constructive partners in the design of UHC-oriented financing policies to ensure universal and high-quality family planning access.
Humanitarian relief must involve, and be accountable to, the crisis-affected people it serves.
Versions of this principle can be found in most foundational humanitarian documents, and it features prominently in recent reform commitments including the 2016 Grand Bargain. Yet the power structures that shape international humanitarian response are not driven by, or accountable to, the people that they exist to serve. They are still engaged more as passive recipients of aid than as a force shaping humanitarian priorities. Living up to the aspiration of people-driven humanitarian action will require uncomfortable – but overdue – changes to the humanitarian system’s incentive structures and power dynamics.
Gautam Rao will talk about his new research, which examines whether evidence changes the beliefs and actions of policy makers. His findings show that policy makers do update their beliefs and do make different policy decisions when presented with new evidence. This research is particularly fascinating for anyone working in policy-influencing roles or in think tanks as it provides direct evidence that providing research information to political leaders can lead to policy change.
The World Bank’s Disease Control Priorities, Third Edition (DCP3) defines a model concept of essential universal health coverage (EUHC) with 218 interventions that provides a starting point for country-specific analysis of priorities. Assuming steady-state implementation by 2030, EUHC in lower-middle-income countries would reduce premature deaths by an estimated 4.2 million per year. Estimated total costs prove substantial: about 9·1% of (current) gross national income (GNI) in low-income countries and 5.2% of GNI in lower-middle-income countries.
Please join the Center for Global Development for this conversation with Devex’s president & editor-in-chief, Raj Kumar, to discuss his book The Business of Changing the World, which has been called the 'go to primer' on the people, ideas and tech disrupting the aid industry. Caroline Atkinson, former head of global policy at Google, will moderate the conversation on how nontraditional models of philanthropy and aid are empowering the world's poorest people to make progress.
Quality affordable generic medicines play a vital role in health systems around the world. Healthy competition from quality generic medicines can help keep prices in check—a shared concern across high-income and low- and middle-income countries. But CGD’s Working Group on the Future of Global Health Procurement found that markets for generic medicines in many low- and middle-income countries are failing. According to the final report, weak and under-resourced regulatory and quality control systems in many countries can often lead healthcare workers and patients to opt for more expensive branded medicines as a proxy for quality.